Tag: Perzea

Perzea

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

up18news

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar, enhancing access to innovative, cost-effective breast cancer treatment. Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted […]

Continue Reading
Hetero Healthcare launched Perzea, an affordable Pertuzumab biosimilar -pnn

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

up18news

Hyderabad (Telangana) [India], September 25: Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive breast cancer. This initiative underlines the critical need for advanced cancer treatment accessibility in the country. Closing the Treatment Gap Pertuzumab, a globally accepted monoclonal antibody therapy, […]

Continue Reading
Hetero Healthcare launched Perzea, an affordable Pertuzumab biosimilar -pnn

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

up18news

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients. […]

Continue Reading